LAB: Labiana Health, S.A. - Summary | Jitta

Labiana Health, S.A.

ESP:LAB

Price
€5.10
Loss Chance
51.0%
3.13JITTA SCORE
92.59%Over Jitta Line
Jitta Ranking
60 / 142
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (48)
Recent Business Performance (53)
Financial Strength (32)
Return to Shareholders (25)
Competitive Advantage (44)
Jitta Signs
Operating MarginInconsistent
Recent Business PerformanceEarning decline 78.20% in the last year
Key Stats
Jitta Score
Jitta Line
3.13
92.59%
2.37
326.27%
2.37
326.27%
0.12
100.00%
3.33
> 1,000%
2.91
100.00%
COMPANY DESCRIPTION
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, North America, and internationally. It offers anesthetics-sedatives, anti-infectives, anti-inflammatories, antiparasitics, hormonals, nutritional products, metabolism regulators, and vitamin products. The company also provides sterile and lyophilized dosage forms, and bacterial vaccines; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, it offers contract development and manufacturing services. The company was founded in 1958 and is based in Pozuelo de Alarcón, Spain.